Fresenius Medical Care AG (FMS)
NYSE: FMS · Real-Time Price · USD
20.95
-0.09 (-0.43%)
Jun 2, 2026, 11:06 AM EDT - Market open
Fresenius Medical Care AG Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 1,166 | 1,191 | 740.87 | 732.46 | 894.33 | 1,219 |
Depreciation & Amortization | 1,569 | 1,500 | 1,742 | 1,752 | 1,838 | 1,624 |
Other Adjustments | 235.4 | 229.45 | 115.75 | 79.59 | 85.18 | 299.6 |
Change in Receivables | -158.1 | -69.06 | -73.48 | -151.84 | -46.68 | -163.2 |
Changes in Inventories | -324.49 | -248.66 | 107.9 | -13.14 | -204.31 | -48.53 |
Changes in Accounts Payable | 225.81 | 12.45 | 155.59 | 108.48 | -356.79 | -363.96 |
Changes in Income Taxes Payable | 209.75 | 236.61 | 482.27 | 472.08 | 325.68 | 313.71 |
Changes in Other Operating Activities | -143.22 | -171.47 | -885.02 | -350.79 | -368.39 | -390.84 |
Operating Cash Flow | 2,745 | 2,681 | 2,386 | 2,629 | 2,167 | 2,490 |
Operating Cash Flow Growth | 13.35% | 12.36% | -9.23% | 21.29% | -12.94% | -41.19% |
Capital Expenditures | -765.3 | -915.37 | -699.36 | -684.6 | -723.99 | -854.36 |
Sale of Property, Plant & Equipment | 16.31 | 16.7 | 14.1 | 16.14 | 36.21 | 24.42 |
Purchases of Investments | -76.02 | -87.52 | -81.5 | -102.36 | -105.64 | -129.08 |
Proceeds from Sale of Investments | 71.27 | 83.5 | 75.13 | 89.6 | 57.67 | 144.52 |
Payments for Business Acquisitions | -14.22 | -21.97 | -23.07 | -35.2 | -59.13 | -434.17 |
Proceeds from Business Divestments | 184.76 | 202.14 | 629.75 | 172.2 | 60.16 | 52.44 |
Investing Cash Flow | -783.77 | -722.53 | -84.94 | -544.23 | -734.73 | -1,196 |
Short-Term Debt Issued | 191.04 | 156.46 | 84.81 | 65.34 | 717.09 | 1,804 |
Short-Term Debt Repaid | -163.33 | -140.81 | -540.5 | -244.98 | -1,302 | -627.25 |
Net Short-Term Debt Issued (Repaid) | 27.71 | 15.65 | -455.69 | -179.64 | -585.16 | 1,177 |
Long-Term Debt Issued | 1,655 | 1,623 | 61.51 | 417.88 | 986.92 | 1,244 |
Long-Term Debt Repaid | -835.04 | -839.59 | -834.46 | -700.66 | -744.62 | -2,083 |
Net Long-Term Debt Issued (Repaid) | 819.65 | 782.97 | -772.95 | -282.79 | 242.3 | -838.91 |
Issuance of Common Stock | - | - | - | - | 20.15 | 6.51 |
Repurchase of Common Stock | -781.5 | -585.29 | - | - | - | - |
Net Common Stock Issued (Repurchased) | -781.5 | -585.29 | - | - | 20.15 | 6.51 |
Common Dividends Paid | -211.26 | -422.52 | -349.16 | -328.62 | -395.56 | -392.46 |
Other Financing Activities | -1,193 | -1,194 | -991.5 | -1,067 | -899.1 | -976.49 |
Financing Cash Flow | -1,701 | -1,403 | -2,569 | -1,859 | -1,617 | -1,024 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -100.33 | -141.48 | 26.2 | -72.61 | -23.16 | 131.23 |
Net Cash Flow | 160.46 | 413.79 | -241.9 | 153.44 | -207.87 | 400.12 |
Free Cash Flow | 1,980 | 1,766 | 1,687 | 1,944 | 1,443 | 1,635 |
Free Cash Flow Growth | 12.13% | 4.67% | -13.24% | 34.70% | -11.73% | -48.60% |
FCF Margin | 10.23% | 9.00% | 8.72% | 9.99% | 7.44% | 9.28% |
Free Cash Flow Per Share | 3.45 | 3.03 | 2.87 | 3.31 | 2.46 | 2.79 |
Levered Free Cash Flow | 2,399 | 2,191 | 212.92 | 1,321 | 841.12 | 1,587 |
Unlevered Free Cash Flow | 1,960 | 1,853 | 1,880 | 2,255 | 1,619 | 1,716 |